Navigation Links
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Date:4/17/2008

WOODCLIFF LAKE, N.J., April 17 /PRNewswire/ -- Eisai Corporation of North America today announces the immediate appointment of Robert Laverty as Vice President of U.S. Corporate Communications. In this newly created position, Mr. Laverty will be responsible for overseeing and coordinating all of Eisai's corporate communications strategies and activities in the United States.

Mr. Laverty brings to Eisai more than 22 years of global corporate, product, policy and research and development communications experience in the pharmaceutical industry. Most recently, he served as Vice President, Global Communications, Malaria Initiatives for Novartis AG, where he oversaw all global communications supporting the company's malaria initiative in the developing world. In addition, Mr. Laverty has held several other executive titles at Novartis Pharmaceuticals Corp, including Vice President, External Communication and Vice President, Global Pharma Media Relations.

Earlier in his career, Mr. Laverty held a number of progressively responsible positions in corporate policy, corporate affairs, and product public affairs at Bristol-Myers Squibb Company. He holds a Bachelor of Science degree in pharmacy from St. John's University, Jamaica, New York.

"Mr. Laverty is a welcome addition to our company and will be instrumental in strengthening Eisai's visibility and presence in the U.S. as a top-20 pharmaceutical company," said Lonnel Coats, President & COO, Eisai Corporation of North America. "With his more than two decades of senior communications expertise in the global pharmaceutical industry, Mr. Laverty's contributions to our company will be invaluable, as we continue to fulfill our human health care (hhc) mission to satisfy unmet medical needs and increase benefits to patients and their families."

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical Research Inc., a clinical development group; Eisai Inc., a commercial operation with manufacturing and marketing/sales functions; MGI PHARMA, Inc., an R&D and commercial operation with manufacturing and marketing/sales functions; and Eisai Machinery U.S.A., which markets and maintains pharmaceutical manufacturing machinery. For more information about Eisai, please visit http://www.eisai.com.


'/>"/>
SOURCE Eisai Corporation of North America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
2. Torchmark Corporation Reports First Quarter 2008 Results
3. Digirad Corporation to Release First Quarter Financial Results on April 24, 2008
4. Otter Tail Corporation Holds 2008 Annual Meeting: Shareholders Elect Directors; Board Declares Quarterly Dividend
5. Microflex Corporation Launches New Website
6. Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics
7. Zipfizz(R) Announces Distribution Deal With the Odom Corporation
8. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
9. BioElectronics Corporations New Commercial Airing Nationally Advertising Initiative Will Reach 15,000,000 Homes Nationwide
10. Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice
11. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 8:00am ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... In ... education and high-level training standards to an international multidisciplinary group of healthcare treatment ... As a way to further its mission at the grassroots level, iaedp launched ...
(Date:1/16/2017)... ... January 16, 2017 , ... NexTec Group has been selected as a ... honored for their accomplishments in the field of midmarket financial software. , Members of ... and innovation. Selection is not based on revenue and those firms chosen represent a ...
(Date:1/15/2017)... Cary, NC (PRWEB) , ... January 15, 2017 ... ... to announce that Albertsons Companies has achieved accreditation for its specialty care services. ... accreditation and its own in-house specialty care service for pharmacy patients. , Accreditation ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor ... Radnor, Pennsylvania. As construction wraps up on the 14,000+ square foot climbing gym, the ... sixth location, including three in New Jersey and two in New York. With this ...
(Date:1/14/2017)... ... , ... AgileMinder develops innovative products and services that bring "Care, Joy and ... Apple as a fun, free emoji sticker pack for iMessage. Use the stickers in ... coded values on The Emoji Scale. , On Apple: "The Emoji Scale by ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), ... Finance and Investment Banking at Eli Lilly & Company, has ... Bott brings over 28 years of senior financial and executive ... ... has established a significant leadership position in financial and business ...
(Date:1/13/2017)... PUNE, India , January 13, 2017 /PRNewswire/ ... research report "Transfection Reagents and Equipment Market by ... Nucleofection), Viral)), Application (Biomedical, Protein Production), End User ... this report studies the global market from 2016 ... USD 1.02 Billion by 2021 from USD 715.4 ...
(Date:1/13/2017)... -- On Thursday, January 12, 2017, the ... S&P 500 edged lower at the closing bell. Seven ... bearish territories. Taking into consideration yesterday,s market sentiment, Stock-Callers.com ... Genetics Inc. (NASDAQ: MYGN ), Qiagen N.V. ... (NASDAQ: INCR ), and La Quinta Holdings ...
Breaking Medicine Technology: